Nuvation Bio (NUVB) Enterprise Value (2023 - 2025)
Historic Enterprise Value for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$549.0 million.
- Nuvation Bio's Enterprise Value rose 1.64% to -$549.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$549.0 million, marking a year-over-year increase of 1.64%. This contributed to the annual value of -$502.7 million for FY2024, which is 1775.5% up from last year.
- Per Nuvation Bio's latest filing, its Enterprise Value stood at -$549.0 million for Q3 2025, which was up 1.64% from -$607.7 million recorded in Q2 2025.
- Over the past 5 years, Nuvation Bio's Enterprise Value peaked at -$461.7 million during Q1 2025, and registered a low of -$646.6 million during Q1 2023.
- In the last 3 years, Nuvation Bio's Enterprise Value had a median value of -$597.0 million in 2024 and averaged -$577.5 million.
- Examining YoY changes over the last 5 years, Nuvation Bio's Enterprise Value showed a top increase of 2266.42% in 2025 and a maximum decrease of 529.36% in 2025.
- Quarter analysis of 3 years shows Nuvation Bio's Enterprise Value stood at -$611.2 million in 2023, then rose by 17.76% to -$502.7 million in 2024, then dropped by 9.22% to -$549.0 million in 2025.
- Its last three reported values are -$549.0 million in Q3 2025, -$607.7 million for Q2 2025, and -$461.7 million during Q1 2025.